Repligen Corp. (RGEN)
125.77
+3.46
(+2.83%)
USD |
NASDAQ |
Jun 08, 14:50
Repligen EPS Diluted (Quarterly) : 0.147 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bio-Techne Corp. | 0.3242 |
| BioLife Solutions, Inc. | 0.0241 |
| MindWalk Holdings Corp. | -0.0609 |
| Maravai Lifesciences Holdings, Inc. | -0.0255 |
| MaxCyte, Inc. | -0.0444 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 8.333M |
| Revenue (Quarterly) | 194.26M |
| Total Expenses (Quarterly) | 185.92M |
| Enterprise Value | 6.801B |
| Gross Profit Margin (Quarterly) | 50.70% |
| Profit Margin (Quarterly) | 4.29% |
| Earnings Yield | 0.72% |
| Operating Earnings Yield | 0.84% |
| Normalized Earnings Yield | 0.6756 |